Phibro Animal Health Corp. A buy JPMorgan Chase & Co.
Start price
07.11.25
/
50%
€38.40
Target price
07.11.26
€43.34
Performance (%)
18.54%
Price
27.02.26
€45.80
Summary
This prediction is currently active. The prediction currently has a performance of 18.54%. Dividends of €0.12 are taken into consideration when calculating the performance. This prediction currently runs until 07.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Phibro Animal Health Corp. A | 5.046% | 5.046% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Phibro Animal Health Corp. A diskutieren
Phibro Animal Health (NASDAQ:PAHC) had its price target raised by analysts at JPMorgan Chase & Co. from $45.00 to $50.00. They now have an "overweight" rating on the stock.
Ratings data for PAHC provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Phibro Animal Health Corp. A
Phibro Animal Health Corp. A
Start price
Target price
Perf. (%)
€25.80
07.07.25
07.07.25
€29.73
07.07.26
07.07.26
78.45%
27.02.26
27.02.26
